Today's News |
Vancouver COVID-19 Therapy Developer AbCellera Eyeing Potential IPO as Early as Fall
Tuesday, July 28, 2020Company Profile | Follow Company
Vancouver, BC, July 28, 2020--A heavily funded Vancouver biotechnology startup whose work to find a treatment for COVID-19 has captured global attention says it could go public as early as this fall to capitalize on investor enthusiasm for health care stocks. AbCellera Biologics Inc. is set to decide in the next two weeks whether to start a process that could see it go public between the Nov. 3 U.S. election and mid-December.
|